Yuanchao Xue

6.7k citations
58 papers · 4.0k indexed · 1 hit paper · h-index 29

Yuanchao Xue

54 papers receiving 3.9k citations

Hit Papers

Reversing a model of Parkinson’s disease with in situ con...3442020202620222024100200300

Peers

Yuanchao Xue
Comparison fields: 5 of 120
  • Cancer Research 1.2k
  • Developmental Neuroscience 218
  • Molecular Biology 3.3k
  • Aging 41
  • Cellular and Molecular Neuroscience 283
Replace Mei Zhong with:
Mei Zhong China
Ewart de Bruijn Netherlands
Jacek Król Switzerland
Rory Johnson Switzerland
Peter Stoilov United States
Lauro Sumoy Spain
Quansheng Du United States
Nicole J. Francis United States
Daniel B. Constam Switzerland
Benjamin P. Lewis United States
Yuanchao Xue relative to Mei Zhong China Mei Zhong's profile →
Citations per field
00.5×
Mei Zhong · 1×
Citations per year

Countries citing papers authored by Yuanchao Xue

Since Specialization
Citations

This map shows the geographic impact of Yuanchao Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanchao Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanchao Xue more than expected).

Fields of papers citing papers by Yuanchao Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanchao Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanchao Xue. The network helps show where Yuanchao Xue may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yuanchao Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuanchao Xue Line = papers co-authored together Yuanchao Xue links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20245
4 202318
5 202369
6 202317
7 20212
8 2021138
9 2021125
10 202161
11 202161
12 20214
13
Reversing a model of Parkinson’s disease with in situ converted nigral neuronsbreakdown →
2020344
14 2018131
15 201832
16 201648
17 201569
18 201520
19 201430
20 2013430

About Yuanchao Xue

Yuanchao Xue is a scholar working on Cancer Research, Molecular Biology and Aging, having authored 58 papers that have together received 4.0k indexed citations. Recurring topics across this work include RNA Research and Splicing (28 papers), RNA modifications and cancer (24 papers), RNA and protein synthesis mechanisms (12 papers), Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers), Genomics and Chromatin Dynamics (6 papers), CRISPR and Genetic Engineering (5 papers) and RNA regulation and disease (4 papers). The work is most often cited by research in Cancer Research (1.2k citations), Developmental Neuroscience (218 citations) and Molecular Biology (3.3k citations). Yuanchao Xue has collaborated with scholars based in China, United States and United Arab Emirates. Frequent co-authors include Xiang‐Dong Fu, Yu Zhou, Yi Zhang, Hui Sun, Changchang Cao, Zhaokui Cai, Xiaorong Zhang, Jie Huang, Hairi Li and Rong Ye. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026